| Literature DB >> 34692587 |
Byung Chan Lee1, Hyoung Ook Kim1, Ho Seok Chung2, Suk Hee Heo1, Yong Yeon Jeong1, Myung Soo Kim2, Eu Chang Hwang2, Seung Il Jung2, Dongdeuk Kwon2, Kwangsung Park2.
Abstract
BACKGROUND: The objective of this study was to evaluate the effect of music with noise-canceling headphones on men undergoing transrectal ultrasound-guided prostate biopsy (TRUSPB) in a prospective randomized study.Entities:
Keywords: Anxiety; Biopsy; Music; Patient comfort; Prostate
Year: 2021 PMID: 34692587 PMCID: PMC8498707 DOI: 10.1016/j.prnil.2021.02.001
Source DB: PubMed Journal: Prostate Int ISSN: 2287-8882
Patients’ characteristics and prebiopsy status comparison between the two groups (n = 94)
| Variables | Total | Group 1 (n = 47) | Group 2 (n = 47) | p value |
|---|---|---|---|---|
| Age (years) | 70.6 ± 8.8 | 70.7 ± 8.6 | 70.4 ± 9.1 | 0.862 |
| Body mass index (kg/m2) | 24.8 ± 3.3 | 24.3 ± 3.3 | 25.4 ± 3.2 | 0.127 |
| Hypertension (%) | 41 (43.6) | 20 (42.6) | 21 (44.7) | 0.835 |
| Diabetes mellitus (%) | 22 (23.4) | 9 (19.1) | 13 (27.7) | 0.330 |
| Cancer history (%) | 23 (24.5) | 10 (21.3) | 13 (27.7) | 0.472 |
| Biopsy history (%) | 22 (23.4) | 8 (17.0) | 14 (29.8) | 0.144 |
| Prostate-specific antigen (ng/mL) | 14.6 ± 26.0 | 12.2 ± 16.8 | 17.1 ± 32.7 | 0.377 |
| Testosterone (ng/mL) | 3.2 ± 1.1 | 3.2 ± 1.2 | 3.1 ± 1.1 | 0.679 |
| Total IPSS score | 13.4 ± 8.1 | 14.6 ± 6.9 | 12.3 ± 9.0 | 0.185 |
| Voiding symptom | 7.8 ± 5.4 | 8.4 ± 4.5 | 7.2 ± 6.2 | 0.274 |
| Storage symptom | 5.7 ± 3.3 | 6.1 ± 3.1 | 5.2 ± 3.4 | 0.149 |
| Maximal flow rate (mL/sec) | 14.5 ± 6.9 | 14.9 ± 6.9 | 14.0 ± 7.0 | 0.519 |
| Postvoid residual urine (mL) | 54.9 ± 62.5 | 51.8 ± 58.4 | 58.1 ± 66.8 | 0.631 |
| IIEF-5 score | 10.2 ± 7.3 | 9.4 ± 7.5 | 11.0 ± 7.1 | 0.294 |
| AMS score | 38.1 ± 12.1 | 38.8 ± 13.6 | 37.4 ± 10.5 | 0.565 |
| Objective parameters | ||||
| Systolic BP (mmHg) | 121.8 ± 13.7 | 122.5 ± 11.7 | 121.1 ± 15.6 | 0.612 |
| Diastolic BP (mmHg) | 74.3 ± 9.8 | 75.5 ± 8.9 | 73.1 ± 10.7 | 0.234 |
| Heart rate (beats/min) | 69.5 ± 7.6 | 69.9 ± 7.7 | 69.1 ± 7.5 | 0.636 |
| Respiratory rate (breaths/min) | 19.9 ± 0.6 | 19.9 ± 0.6 | 19.9 ± 0.6 | 1.000 |
| Arterial oxygen saturation (%) | 96.4 ± 1.4 | 96.4 ± 1.4 | 96.4 ± 1.4 | 0.885 |
| Subjective parameters | ||||
| STAI-state score | 46.0 ± 6.2 | 45.9 ± 7.5 | 46.2 ± 4.7 | 0.843 |
| STAI-trait score | 42.8 ± 7.2 | 42.5 ± 8.2 | 43.1 ± 6.2 | 0.681 |
| Prostate volume | 41.2 ± 19.8 | 42.4 ± 22.0 | 40.0 ± 17.5 | 0.556 |
| Postbiopsy Pca diagnosis (%) | 52 (55.3%) | 24 (51.1) | 28 (55.3) | 0.407 |
IPSS, international prostate symptom score; IIEF, international index of erectile function; AMS, aging males' symptoms; BP, blood pressure; STAI, state-trait anxiety inventory; Pca, prostate cancer.
Comparison of postbiopsy parameters between the two groups
| Variables | Total | Group 1 (n = 47) | Group 2 (n = 47) | p value |
|---|---|---|---|---|
| Objective parameters | ||||
| Systolic BP (mmHg) | 137.3 ± 15.4 | 140.2 ± 15.2 | 134.5 ± 15.2 | 0.071 |
| Postbiopsy change | 15.5 ± 13.0 | 17.7 ± 13.4 | 13.4 ± 12.4 | 0.113 |
| Diastolic BP (mmHg) | 80.1 ± 10.2 | 81.1 ± 9.6 | 79.2 ± 9.1 | 0.367 |
| Postbiopsy change | 5.9 ± 5.4 | 5.6 ± 5.9 | 6.1 ± 5.0 | 0.651 |
| Heart rate (beats/min) | 72.2 ± 9.7 | 75.4 ± 9.1 | 73.0 ± 10.3 | 0.233 |
| Postbiopsy change | 4.8 ± 6.8 | 5.6 ± 6.8 | 3.9 ± 6.9 | 0.241 |
| Respiratory rate (breaths/min) | 20.0 ± 0.1 | 20.0 ± 0.1 | 20.0 ± 0.0 | 0.320 |
| Postbiopsy change | 0.1 ± 0.6 | 0.1 ± 0.6 | 0.1 ± 0.6 | 0.862 |
| Arterial oxygen saturation (%) | 96.6 ± 2.1 | 96.4 ± 2.4 | 96.7 ± 1.9 | 0.412 |
| Postbiopsy change | 0.1 ± 2.4 | −0.1 ± 2.5 | 0.3 ± 2.4 | 0.425 |
| Subjective parameters | ||||
| STAI-state score | 42.4 ± 7.9 | 44.7 ± 8.3 | 40.1 ± 6.8 | 0.004 |
| Postbiopsy change | −3.6 ± 5.8 | −1.2 ± 6.1 | −6.1 ± 4.5 | 0.001 |
| VAS score | 3.9 ± 1.8 | 4.4 ± 1.5 | 3.5 ± 1.9 | 0.009 |
| Satisfaction | 6.5 ± 2.0 | 5.9 ± 2.0 | 7.1 ± 1.8 | 0.004 |
| Willing to repeat biopsy | 5.8 ± 2.0 | 5.2 ± 2.0 | 6.4 ± 1.9 | 0.003 |
BP, blood pressure; STAI, state-trait anxiety inventory; VAS, visual analog scale.
Figure 1Box plots of postbiopsy subjective parameters between the two groups. Box plots show postbiopsy subjective parameters including STAI-state (Trait Anxiety Inventory), VAS (visual analog scale), satisfaction, and willingness to repeat biopsy between the two groups. The postbiopsy STAI-state score and the postbiopsy VAS score for pain show significantly lower in Group 2 than Group 1 (p = 0.004 and 0.009, respectively), and VAS scores for the patients' satisfaction and willingness to repeat the procedure are significantly higher in Group 2 than in Group 1 (p = 0.004 and 0.003, respectively).